Berkshire Biomedical Corporation — Form C-AR (Regulation Crowdfunding)
Berkshire Biomedical Corporation of Dallas, TX filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2026-03-31.
Offering
- Filed: 2026-03-31
- Form: C-AR
- Accession: 0002048576-26-000002
Issuer
- CIK: 0002048576
- Website: https://www.berkshirebiomedical.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2016-07-19
- Address: 5950 Berkshire Ln., Suite 375, Dallas, TX, 75225
- Employees: 3
Financials (as filed)
- Total assets (most recent): $213K
- Cash (most recent): $132K
- Revenue (most recent): $197K
- Revenue (prior): $222K
- Net income (most recent): $59K
- Net income (prior): $-4.3M
- Long-term debt: $1.0M
People (7)
| Name | Role | Location |
|---|
| John Timberlake | President and CEO, and Board Member | Bridgewater, NJ |
| John Timberlake | President & CEO | Bridgewater, NJ |
| John Timberlake | President, CEO, CFO, and Director | Bridgewater, NJ |
| Susan Owen | Director | DALLAS, TX |
| Thomas M Rouse | Board Chair | DALLAS, TX |
| Thomas Rouse | Chairman, Director | DALLAS, TX |
| Thomas Rouse | Chairman of the Board | DALLAS, TX |
Reg CF filing history (5)
More